Works matching IS 1699048X AND DT 2020 AND VI 22 AND IP 2
Results: 11
2019 SEOM guidelines (the end of a decade).
- Published in:
- 2020
- By:
- Publication type:
- Editorial
SEOM clinical guideline for secondary prevention (2019).
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 2, p. 187, doi. 10.1007/s12094-020-02302-0
- By:
- Publication type:
- Article
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019).
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 2, p. 245, doi. 10.1007/s12094-020-02295-w
- By:
- Publication type:
- Article
SEOM clinical guideline for treatment of kidney cancer (2019).
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 2, p. 256, doi. 10.1007/s12094-019-02285-7
- By:
- Publication type:
- Article
SEOM clinical guideline thyroid cancer (2019).
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 2, p. 223, doi. 10.1007/s12094-019-02284-8
- By:
- Publication type:
- Article
SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019).
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 2, p. 236, doi. 10.1007/s12094-019-02259-9
- By:
- Publication type:
- Article
SEOM clinical guideline on hereditary colorectal cancer (2019).
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 2, p. 201, doi. 10.1007/s12094-019-02272-y
- By:
- Publication type:
- Article
SEOM clinical guidelines for cervical cancer (2019).
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 2, p. 270, doi. 10.1007/s12094-019-02271-z
- By:
- Publication type:
- Article
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019).
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 2, p. 171, doi. 10.1007/s12094-019-02263-z
- By:
- Publication type:
- Article
SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 2, p. 193, doi. 10.1007/s12094-019-02262-0
- By:
- Publication type:
- Article
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019).
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 2, p. 213, doi. 10.1007/s12094-019-02273-x
- By:
- Publication type:
- Article